Stock prices often react negatively to earnings reports and future guidance that do not meet or exceed analyst expectations. In this case, TMCI's announcement of lower-than-expected Q1 financial results and FY24 revenue guidance is likely to lead to a decrease in investor confidence and a short-term decline in stock price.